These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 34436610)
21. Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y Russo JJ; James TE; Ruel M; Dupuis JY; Singh K; Goubran D; Malhotra N; Rubens F; Chong AY; Hibbert B; Boland P; Tran DT; Tanguay JF; Lordkipanidzé M; Perrault L; Wells GA; Bourke M; Chan V; So DY Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):543-553. PubMed ID: 29313713 [TBL] [Abstract][Full Text] [Related]
22. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Hansson EC; Jidéus L; Åberg B; Bjursten H; Dreifaldt M; Holmgren A; Ivert T; Nozohoor S; Barbu M; Svedjeholm R; Jeppsson A Eur Heart J; 2016 Jan; 37(2):189-97. PubMed ID: 26330426 [TBL] [Abstract][Full Text] [Related]
23. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial. Tomaniak M; Chichareon P; Onuma Y; Deliargyris EN; Takahashi K; Kogame N; Modolo R; Chang CC; Rademaker-Havinga T; Storey RF; Dangas GD; Bhatt DL; Angiolillo DJ; Hamm C; Valgimigli M; Windecker S; Steg PG; Vranckx P; Serruys PW; JAMA Cardiol; 2019 Nov; 4(11):1092-1101. PubMed ID: 31557763 [TBL] [Abstract][Full Text] [Related]
24. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis. Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473 [TBL] [Abstract][Full Text] [Related]
25. Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor. Hansson EC; Rexius H; Dellborg M; Albertsson P; Jeppsson A Eur J Cardiothorac Surg; 2014 Oct; 46(4):699-705; discussion 705. PubMed ID: 24482383 [TBL] [Abstract][Full Text] [Related]
26. Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy. Schlachtenberger G; Deppe AC; Gerfer S; Choi YH; Zeriouh M; Liakopoulos O; Wahlers TCW Thorac Cardiovasc Surg; 2020 Dec; 68(8):714-722. PubMed ID: 32593177 [TBL] [Abstract][Full Text] [Related]
27. Comparison of major bleeding in patients with acute coronary syndrome that underwent coronary artery bypass grafting treated with clopidogrel or ticagrelor: a systematic review and meta-analysis. Rohman MS; Purnamasari Y; Ilmawan M; Mahdi BA; Tamara F; Mahendra AI; Mazen M; Heriansyah T; Yamin M; Pikir BS; Fajar JK F1000Res; 2020; 9():99. PubMed ID: 33732438 [No Abstract] [Full Text] [Related]
28. Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes. Diab S; Arazi M; Sternik L; Raanani E; Kachel E; Grosman-Rimon L; Shalabi A; Amir O; Carasso S J Cardiothorac Surg; 2021 May; 16(1):139. PubMed ID: 34022927 [TBL] [Abstract][Full Text] [Related]
29. Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe? Charif F; Hamdan R; Youness G; El Zein A; Issa M; Jassar Y; Younes M; Saab M J Cardiothorac Surg; 2019 Nov; 14(1):202. PubMed ID: 31775803 [TBL] [Abstract][Full Text] [Related]
30. Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial. Malm CJ; Alfredsson J; Erlinge D; Gudbjartsson T; Gunn J; James S; Møller CH; Nielsen SJ; Sartipy U; Tønnessen T; Jeppsson A Am Heart J; 2023 May; 259():1-8. PubMed ID: 36681173 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome. Li D; Sun Y; Ye X; Li L; Chen Y; Wang D Adv Ther; 2022 Jan; 39(1):754-766. PubMed ID: 34904209 [TBL] [Abstract][Full Text] [Related]
32. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. Sardella G; Beerkens FJ; Dangas G; Cao D; Baber U; Sartori S; Cohen DJ; Briguori C; Gil R; Nicolas J; Zhang Z; Dudek D; Kunadian V; Kornowski R; Weisz G; Claessen B; Marx S; Escaned J; Huber K; Collier T; Moliterno DJ; Ohman EM; Krucoff MW; Kastrati A; Steg PG; Angiolillo DJ; Mehta S; Shlofmitz R; Sharma S; Pocock S; Gibson CM; Mehran R EuroIntervention; 2022 Dec; 18(11):e897-e909. PubMed ID: 35979636 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Aspirin Monotherapy versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting. Hess NR; Sultan I; Wang Y; Thoma F; Kilic A Am J Cardiol; 2021 Jun; 148():44-52. PubMed ID: 33667447 [TBL] [Abstract][Full Text] [Related]
34. Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery. Qu J; Zhang H; Rao C; Chen S; Zhao Y; Sun H; Song Y; Liu S; Wang L; Feng W; Wang S; Hu S; Zheng Z J Am Heart Assoc; 2021 Jun; 10(11):e020413. PubMed ID: 33998246 [TBL] [Abstract][Full Text] [Related]
35. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis. Agrawal A; Kumar A; Majid M; Badwan O; Arockiam AD; El Dahdah J; Syed AB; Schleicher M; Reed GW; Cremer PC; Griffin BP; Menon V; Wang TKM Heart; 2024 Feb; 110(5):323-330. PubMed ID: 37648436 [TBL] [Abstract][Full Text] [Related]
36. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. Baber U; Dangas G; Angiolillo DJ; Cohen DJ; Sharma SK; Nicolas J; Briguori C; Cha JY; Collier T; Dudek D; Džavik V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta S; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM; Mehran R Eur Heart J; 2020 Oct; 41(37):3533-3545. PubMed ID: 33085967 [TBL] [Abstract][Full Text] [Related]
37. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial. Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164 [TBL] [Abstract][Full Text] [Related]
38. [Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery]. Zyryanov SK; Belousov DY; Afanasyeva EV; Dumchenko EV Ter Arkh; 2016; 88(9):39-49. PubMed ID: 27735912 [TBL] [Abstract][Full Text] [Related]
39. The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y O'Donoghue ML; Murphy SA; Sabatine MS Circulation; 2020 Aug; 142(6):538-545. PubMed ID: 32551860 [TBL] [Abstract][Full Text] [Related]
40. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial. Chichareon P; Modolo R; Kerkmeijer L; Tomaniak M; Kogame N; Takahashi K; Chang CC; Komiyama H; Moccetti T; Talwar S; Colombo A; Maillard L; Barlis P; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Mehran R; Serruys PW JAMA Cardiol; 2020 Jan; 5(1):21-29. PubMed ID: 31693078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]